PLAT and ischemic stroke: Currently, endovascular treatment is one of the identified therapies for ischemic stroke in addition to intravenous thrombolysis employing recombinant tissue plasminogen activator (rt‐PA), which is the only US FDA‐approved medicine for ischemic stroke in the ultra‐early stage (Goyal et al., 2016).